Clinical Trials
9 trialsNCT05191940 2026-03-20
LAPC
EBG MedAustron GmbH
Phase NA Recruiting
NCT05854368 2025-05-16
PREGASIGN#1
Institut Pasteur
Phase NA Recruiting
NCT04875871 2025-05-11
PARTICLE-PATHY
EBG MedAustron GmbH
Phase NA Terminated
NCT06703632 2025-02-27
MS-Prevecol
ADVANCED MARKER DISCOVERY S.L.
Phase NA Recruiting
NCT06738511 2024-12-17
Validation of a Molecular Signature for Early Detection of Colorectal Cancer
ADVANCED MARKER DISCOVERY S.L.
Phase NA Completed
NCT06033183 2024-11-22
FOCUSO
Neolys
Phase NA Recruiting
NCT05133128 2024-02-22
IMMUNOPBMC
Servier
Phase NA Terminated
NCT00685750 2019-06-20
Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
GlaxoSmithKline
Phase NA Terminated
NCT00436189 2008-04-30
Assess Cancer in Ovarian Tumors With Biomarkers.
Ciphergen Biosystems
Phase NA Completed